GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

TransGenic Group 2342.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

203

+3.05%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥13.17bn

FY2017FY2026

Net income

−¥77.3m

FY2017FY2026

Free cash flow

−¥42.6m

FY2017FY2026

Shareholders' equity

¥4.78bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥13.17bn¥13.01bn¥13.08bn¥11.43bn¥12.58bn¥11.05bn¥11.05bn¥8.67bn¥3.60bn¥2.30bn
Gross profit¥2.43bn¥2.17bn¥2.25bn¥1.99bn¥3.84bn¥2.78bn¥1.78bn¥1.50bn¥822.5m¥748.9m
Research and development—¥83.4m¥61.3m¥37.8m¥40.2m¥26.8m¥38.3m¥51.6m¥55.2m¥48.0m
Operating income¥138.0m−¥640.5m¥103.2m−¥303.7m¥1.84bn¥895.6m¥62.7m¥270.1m¥60.6m¥153.9m
Net income−¥77.3m−¥1.09bn¥4.1m−¥409.7m¥1.88bn¥546.3m−¥440.7m¥202.2m¥20.9m¥80.7m
Diluted earnings per share-4.64-65.430.25-24.31111.3032.48-25.3811.641.225.43

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥9.74bn¥9.59bn¥9.84bn¥10.68bn¥10.44bn¥8.93bn¥7.57bn¥6.48bn¥5.93bn¥3.90bn
Cash and short-term investments¥2.13bn¥2.56bn¥2.48bn¥3.46bn¥4.62bn¥3.03bn¥1.80bn¥1.28bn¥1.77bn¥1.06bn
Total liabilities¥4.90bn¥4.73bn¥3.84bn¥4.56bn¥3.80bn¥3.89bn¥3.15bn¥1.59bn¥1.59bn¥729.1m
Debt¥2.09bn¥2.58bn¥2.26bn¥2.43bn¥1.86bn¥2.06bn¥1.83bn¥675.7m¥951.9m¥245.8m
Shareholders' equity¥4.78bn¥4.76bn¥5.89bn¥6.02bn¥6.53bn¥4.92bn¥4.42bn¥4.89bn¥4.34bn¥3.17bn
Shares outstanding17m17m17m17m17m17m17m17m17m15m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥25.9m¥94.1m−¥392.5m−¥1.43bn¥1.79bn¥1.22bn−¥21.0m¥147.7m¥219.1m¥232.8m
Capital spending−¥68.5m−¥175.4m−¥265.7m−¥306.3m−¥532.0m−¥145.8m−¥256.7m−¥320.5m−¥74.1m−¥127.1m
Free cash flow−¥42.6m−¥81.4m−¥658.1m−¥1.74bn¥1.26bn¥1.08bn−¥277.7m−¥172.8m¥145.0m¥105.7m
Dividends paid−¥177,000−¥49.6m−¥83.8m−¥100.9m−¥52.1m−¥52.0m−¥52.0m−¥52.0m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥3.66bn¥3.48bn¥3.47bn¥3.03bn¥3.20bn¥3.20bn¥3.50bn¥3.43bn
Gross profit¥714.6m¥595.5m¥614.4m¥613.8m¥610.0m¥459.0m¥593.2m¥613.2m
Operating income¥163.5m¥33.4m¥33.2m¥26.1m¥45.3m−¥133.4m−¥14.9m−¥5.0m
Net income¥136.0m−¥105.3m−¥1.5m¥2.6m¥27.0m−¥798.0m−¥109.4m−¥82.8m
Diluted earnings per share8.17-6.32-0.090.161.62-47.92-6.57-4.97
Total assets¥9.73bn¥9.74bn¥10.34bn¥9.64bn¥9.72bn¥9.59bn¥10.45bn¥10.58bn
Cash and short-term investments¥2.26bn¥2.13bn¥2.24bn¥2.21bn¥2.30bn¥2.56bn¥2.25bn¥2.27bn
Debt¥1.76bn¥2.09bn¥1.84bn¥2.86bn¥1.60bn¥2.58bn¥1.43bn¥2.68bn
Shareholders' equity¥4.88bn¥4.78bn¥4.94bn¥4.80bn¥4.79bn¥4.76bn¥5.56bn¥5.66bn

Financial ratios

Data as of 16 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin18.5%16.7%17.2%17.5%30.5%25.1%—
Operating margin1.0%-2.0%0.8%-0.2%14.6%8.1%—
Net margin-0.6%-8.4%0.0%-3.6%14.9%4.9%—
Return on equity-1.6%-22.9%0.1%-6.8%28.7%11.1%—
Return on assets-0.8%-11.4%0.0%-3.8%18.0%6.1%—
Free cash flow yield2.5%7.2%-3.4%-29.8%61.5%36.3%—
Revenue growth1.3%-0.6%14.5%-9.1%13.9%-0.0%—
Earnings growth-92.9%-26774.2%-101.0%-121.8%243.5%-224.0%—
Current ratio1.74x2.05x2.69x2.76x2.90x2.69x—
Debt to equity0.44x0.54x0.38x0.40x0.28x0.39x—
Equity ratio49.1%49.7%59.9%56.3%62.6%55.1%—
Interest coverage3.01x-6.96x2.17x-0.88x81.17x31.55x—
R&D as a share of sales—0.6%0.5%0.3%0.3%0.2%0.3%
Buybacks as a share of market value0.0%0.0%1.2%0.0%-0.2%3.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.8%3.6%19.1%
Operating income—-31.2%10.6%
Net income-42.7%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin17.6%17.4%20.8%20.5%
Operating margin-1.9%-1.4%2.7%2.6%
Net margin-4.5%-3.1%1.1%0.7%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-44.6-4.7—-10.72.913.8-18.134.5340.9104.8
Price to sales0.30.40.20.40.40.70.70.82.03.7

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 28 Mar 2025.

FY2025FY2024FY2023FY2022
Paid in the year6.003.003.003.00
  • 100-for-1 split · 27 Mar 2013
  • 1000-to-1 reverse split · 2 Oct 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.